Press Release

Best in Class: Scottsdale Wound Management Guide

Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips

Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More

2009 WOUNDS Article Index

CLICK HERE TO VIEW OUR 2009 Article INDEX

Today's Wound Clinic

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »

Education

ON-DEMAND WEBCAST - How Advanced Wound Dressing Technology Helps Progress Chronic Wound Healing
Non-Accredited

Taking the Complexity Out of Diabetic Foot Management - Complimentary On-Demand Webcast
Non-Accredited

Simple Steps in Wound Healing to Achieve Success for Your Patients and Practice - Complimentary On-Demand Webcast
Non-Accredited

CLINICAL EVENTS CALENDAR

Wound Clinic Business Meeting
Start Date:
June 18, 2010
End Date:
June 18, 2010
Crowne Plaza, Chicago O'Hare

http://www.woundclinicbusiness.com/registration
SAWC Fall
Start Date:
September 23, 2010
End Date:
September 25, 2010
Anaheim Convention Center

http://fall.sawc.net/

WOUNDS News Wire

MediPurpose® Signs Exclusive Agreement to Distribute Wound Care Products from Egypt-based Company

MediPurpose^® (Norcross, GA), a medical device innovation and medical product distribution company, announced that it has signed an exclusive agreement to distribute advanced wound care products from Egypt-based OEM Pharmaplast (Alexandria, Egypt). The milestone agreement represents the foundation for MediPurpose's recently launched wound care division. For Pharmaplast, it enables access to an expanded market for its products within the Americas while continuing to expand their worldwide presence.

Darg Medical Group to Distribute Novel RTD Wound Dressing

Darg Medical Group LLC (Iron Station, NC) and Global Products Technology LLC (Holly Springs, NC) announced the signing of a multiyear distribution agreement for RTD^™wound care dressings. RTD wound dressing is a wound care dressing for a broad spectrum of both acute and chronic wounds. The dressing was developed by George Walter Medical and is the only complete category crossover wound care dressing available commercially. RTD uses a patented process to produce and manufacture the dressings, which have broad applicability on various wounds.

TheraSkin® is Awarded the APMA Seal of Approval

Soluble Systems LLC (Newport News, VA) announced that American Podiatric Medical Association (APMA) has awarded its Seal of Approval for TheraSkin^®. TheraSkin is a cryo-preserved human skin allograft with both epidermis and dermis layers. When applied to a wound that is not healing properly, the skin allograft can jumpstart the healing process.

Thermal Imaging System Predicts Pressure Ulcers and Other Health Risks Bedside

WoundVision^™(Indianapolis, IN), healthcare industry pioneer in advanced wound detection technology, recently introduced a revolutionary predictive bedside thermographic imaging system. The WoundVision^® system brings knowledge to the bedside by acquiring, analyzing, and applying essential patient data to inform healthcare providers in the development of effective treatment and care plans.

Ubuntu International Conference — A Global Wound Healing Initiative

The Wound Healing Fraternity across the globe will be coming together at this extraordinary event to find and uncover wounds that are either hidden or neglected within different community settings worldwide. You are herewith invited to join the world at the Cape Town International Conference Centre from September 5–8, 2010 for this unique interactive initiative.

The theme of this conference is UBUNTU — a global wound healing initiative: Uncovering the hidden wound. The basic tenet of UBUNTU is motho ke motho ka batho ba bang — a person is a person through other people.

UPDATE: Univ. of Miami's Efforts in Haiti—How You Can Help

(Dr. Robert Kirsner provided this update):

The University of Miami's "Hospital" remains fully functional with approximately 240 beds and 4 ORs, an ER, and an ICU. A recent report (March 11) in the NEJM highlights the initial efforts. While the logistics remain essentially unchanged from the perspective of supplies and volunteers, Project Medishare has taken the leadership role in administration and University

Bluestar Silicones Unveils Skin Adhesive Silicone Elastomers for Wound Care Applications

Bluestar Silicones (Anaheim, Calif), one of the world’s leading fully integrated global silicones manufacturers, recently launched a new line of skin adhesive elastomer gels. The new Silbione® Silicone Gels provide gentle, non-irritating adhesion for a range of wound and skin care applications. Wound care is a growing market for silicones because of the material’s property profile and biocompatibility. The gel skin adhesives are two-part, platinum-catalyzed silicone gel elastomers that are manufactured in a clean environment to ensure healthcare grade levels of purity and quality.

Celox™ Stops Bleeding and Saves Lives on The Battlefield

Celox™ granules are high surface area flakes. When the flakes come in contact with blood, the product forms a robust gel like clot in 30 seconds. It works independently of the body’s normal clotting processes. The product’s clotting ability has been proven to work in the cold (hypothermia) or in the presence of common anti-coagulants such as warfarin. Since it does not generate heat, Celox will not burn the casualty or care giver. The product is made with chitosan, which is broken down by lysozyme, a human enzyme that leaves glucosamine, a sugar that is normally found in the body.

FDA Issues Guidance for Derma Sciences’ Exclusive Wound Dressing With pDADMAC

Derma Sciences, Inc. (Princeton, NJ), a specialty medical device/pharmaceutical company specializing in advanced wound care, recently announced that the US Food and Drug Administration (FDA) has issued its Guidance Document to support the classification of the company's BIOGUARD™ barrier gauze wound dressings as Class II medical devices. This novel wound dressing received its initial market clearance on February 25, 2009, via the FDA's de novo review process, a special clearance program for medical devices that are found to be "not substantially equivalent" to any predicate device.

Gauze-based NPWT Achieves Same Treatment Goals as Foam-based NPWT

The Advanced Wound Management Division of Smith & Nephew Inc, a subsidiary of Smith & Nephew Plc (St. Petersburg, FL) highlighted the results of a multi-center study that demonstrated that gauze-based negative pressure wound therapy (NPWT) achieves many of the common treatment goals defined for foam-based NPWT systems. These goals include a reduction in wound dimension, exudate, and improvement in granulation tissue. The results of this study were presented in a poster session at the 24th Annual Clinical Symposium on Advances in Skin and Wound Care in San Antonio, Texas.